Athenex, Inc.
ACETAMIDO-PHENYLTETRAZOLE DERIVATIVES AND METHODS OF USING THE SAME
Last updated:
Abstract:
The present disclosure relates to compounds of Formula (IA) ##STR00001## and to their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for the treatment of disorders in which P-glycoprotein and/or cytochrome P450 (e.g. CYP3A4) is modulated (e.g., cancers which have developed multi-drug resistance).
Status:
Application
Type:
Utility
Filling date:
7 Oct 2021
Issue date:
7 Apr 2022